PRTX-100: Phase Ib ongoing

Protalex will continue enrollment of the open-label, dose-escalation, French Phase Ib PRTX-100-203 trial evaluating 4 weekly doses of 3, 6, 12, 18 and 24 ug/kg IV PRTX-100 in up to 30 patients followi...